None listed
Conditions
Interventions
Intervention1: Clay Mask: Route of Administration: Topical
Mode of Usage:
Step 1 Cleanse: Wash your face with warm water and clean with
standard cleanser.
Step 2 Apply the mask: Take 4-5g of the produ
Sponsors
DPKA Universal Consumer Venture Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age: 21 to 50 years (both inclusive) old at the time of consent. 2) Sex: Healthy human non-pregnant/non-lactating females. 3) Frequent users of international brands. 4) Females of childbearing potential must have a self-reported negative urine pregnancy test. 5) Subjects are generally in good general health as determined from recent medical history. 6) The subject is willing and able to follow the study directions, participate in the study, returning for all specified visits. 7) The subject must be able to understand and provide written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Subjects must not be enrolled in the study if they meet any one of the following criteria: 1) Subject with known allergy or sensitization to cosmetic products. 2) The subject has clinically significant skin disease, which may contraindicate participation, including psoriasis, eczema, Skin cancer or other skin pathology. 3) Medication which may affect skin response and/or past medical history. 4) Individuals with active (flaring) disease or chronic skin allergies (atopic dermatitis/eczema) or those who have recently undergone treatment for skin cancer (within the last 12 months) in the area of testing on the forehead, nose and the cheeks. 5) Female volunteers who have started a new hormonal birth control agent or switched to a hormonal birth control agent within the past 60 days. 6) Individuals who have had any medical or cosmetic procedure, such as laser resurfacing, or plastic surgery to the test site (face) within the last 6 months. This includes botulinum toxin, dermal fillers, collagen or other similar cosmetic procedure. 7) Individuals who are currently using or during the past 14 days have used a retinoid such as tretinoin, adapalene, or retinol containing agents or a hydroquinone containing agent. 8) Individuals who have used mineral clay masks on their face within the last 14 days. 9) Individuals who have been on any topical prescribed medications for the past 2 weeks. 10) An individual who has a medical condition or is taking or has taken a medication which, in the Investigator’s judgment, makes the subject ineligible or places the subject at undue risk. 11) Participation in other clinical studies simultaneously.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in skin hydration 2. Change in Skin Radiance 3. Change in Sebum Secretion 4. Change in number of pores, visible pores area, & clogged pores 5. Improvement in visible pores areaTimepoint: From Baseline to Day 01 & Day 03 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in facial PhotographsTimepoint: From Baseline to Day 01;To evaluate the product effectiveness in terms of subject response indexTimepoint: From Baseline to Day 01 & Day 03 | — |
Countries
India
Contacts
Public ContactMaheshvari Patel
NovoBliss Research Private Limited
Outcome results
None listed